Ikena Oncology, Inc. (IKNA) Financials
Stock symbol IKNA is outdated, potentially delisted? Maybe it is available on other exchange?
IKNA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2024 | 149.0 million | 14.8 million |
| June 30, 2024 | 157.5 million | 14.6 million |
| March 31, 2024 | 172.8 million | 17.4 million |
| Dec. 31, 2023 | 192.1 million | 22.3 million |
IKNA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2024 | -8.9 million | 1.0 million |
| June 30, 2024 | -12.5 million | 1.3 million |
| March 31, 2024 | -18.3 million | 2.0 million |
| Dec. 31, 2023 | -22.1 million | 1.8 million |
IKNA Net Income
No data available :(
IKNA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2024 | 138.0 million | 4.5 million | - |
| June 30, 2024 | 145.4 million | 5.4 million | 9.1 million |
| March 31, 2024 | 157.3 million | 6.3 million | 9.7 million |
| Dec. 31, 2023 | 175.5 million | 7.2 million | 10.7 million |
IKNA Shares Outstanding
IKNA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2024 | - | 6.8 million | 4.8 million | - |
| June 30, 2024 | - | 9.7 million | 5.3 million | - |
| March 31, 2024 | - | 9.4 million | 6.0 million | - |
| Dec. 31, 2023 | 262000 | 14.0 million | 8.3 million | -1 |
IKNA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2024 | - | - |
| June 30, 2024 | - | 92000 |
| March 31, 2024 | - | 219000 |
| Dec. 31, 2023 | 659000 | 305000 |
IKNA
Price: $17.16
52 week price:
Earnings Per Share: -7.68 USD
P/E Ratio: -2.23
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 7489
Market Capitalization: 718.8 million